On-site quantification of human urinary albumin by a fluorescence immunoassay.

Microalbuminuria (MAU), defined as a urinary albumin excretion of 30–300 mg/day, indicates a high probability of renal damage and is an accepted predictor for the early diagnosis of nephropathy in diabetic patients (1)(2). In addition, MAU has diagnostic implications in pregnancy as a predictive marker of preeclampsia (3)(4) and may play a role in identifying high risk of developing complications from cardiovascular diseases even in nondiabetic patients (5)(6)(7). Dye-binding assays can measure serum albumin but are too insensitive for MAU testing, making immunochemical assays the most widely used MAU methods (8). These immunoassays include immunoturbidimetry, immunofluorescence, ELISA, RIA, and zone immunoelectrophoresis. Recently, Kessler and coworkers (9)(10) introduced a laser-induced fluorescence system coupled to an automated centrifugal analyzer as a nonimmunologic assay for urinary albumin. Their system was based on the probe Albumin Blue 670/580, which becomes highly fluorescent on binding to albumin. We report a fluorescence immunochromatography assay (ICA) for quantitative determination of albumin in urine. The assay system consists of an ICA test strip in a disposable cartridge, a fluorescently labeled detector, and a laser fluorescence reader. Basically, the assay system adopts the inherent simplicity of a lateral-flow ICA and uses a competitive immunoassay mode with a simple, one-step operation (11). Briefly, fluorescently labeled albumin in the detector buffer competes with albumin in the sample for binding to an anti-albumin antibody immobilized on the test strip matrix. The more albumin is in the sample, the less the fluorescently labeled albumin reacts with the anti-albumin antibody and, thus, the lower the accumulation of fluorescence in the test line of a test strip. We generated a monoclonal antibody against human albumin (Sigma A8763) as an immunogen and conducted immunizations, cell fusion, and screening of hybridoma cells according to a standard …

[1]  O. Wolfbeis,et al.  Microalbuminuria and borderline-increased albumin excretion determined with a centrifugal analyzer and the Albumin Blue 580 fluorescence assay. , 1997, Clinical chemistry.

[2]  Kie Bong Nahm,et al.  Simplified laser fluorescence scanner for proteomics studies and early cancer diagnosis , 2002, SPIE/COS Photonics Asia.

[3]  T. Deckert,et al.  Relationship Between Blood Pressure and Urinary Albumin Excretion in Development of Microalbuminuria , 1990, Diabetes.

[4]  G. Watts,et al.  Microalbuminuria in Diabetes Mellitus: Review and Recommendations for the Measurement of Albumin in Urine , 1990, Annals of clinical biochemistry.

[5]  T. Peters,et al.  Serum and urine albumin: a progress report on their measurement and clinical significance. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[6]  H. Keen,et al.  MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.

[7]  P. G. Hill The Measurement of Albumin in Serum and Plasma , 1985, Annals of clinical biochemistry.

[8]  Y. Guan,et al.  Early diagnosis of SARS Coronavirus infection by real time RT-PCR , 2003, Journal of Clinical Virology.

[9]  J. Sung,et al.  Detection of SARS coronavirus in plasma by real-time RT-PCR. , 2003, The New England journal of medicine.

[10]  O. Wolfbeis,et al.  Nonimmunological assay of urinary albumin based on laser-induced fluorescence. , 1992, Clinical chemistry.

[11]  J. B. Park,et al.  Production and characterization of isotype-specific monoclonal antibodies to bovine brain Rab GDI. , 1999, Hybridoma.

[12]  Y. Guan,et al.  Detection of SARS Coronavirus in Patients with Suspected SARS , 2004, Emerging infectious diseases.

[13]  Dong Joon Kim,et al.  A rapid, simple measurement of human albumin in whole blood using a fluorescence immunoassay (I). , 2004, Clinica chimica acta; international journal of clinical chemistry.

[14]  M. Kilby,et al.  Validation of the DCA® 2000 Microalbumin:Creatinine Ratio Urinanalyzer for Its Use in Pregnancy and Preeclampsia , 2003, Hypertension in pregnancy.

[15]  C. Mogensen,et al.  Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.

[16]  Dana V. Devine,et al.  RAMPTM: A Rapid, Quantitative Whole Blood Immunochromatographic Platform for Point-of-Care Testing , 1999 .